Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth A David

Showing results (61-70 of 135) with videos related to

Pageof 14
Sort By:
Annals of Surgical Oncology|September 20, 2025
Social Vulnerability is Associated with Significant Delays to Definitive Surgery for Stages IA to IIIA Non-small Cell Lung Cancer and Consequential Increased Rates of Pathologic UpstagingNicole M Mott, Robert A Meguid, Simran K Randhawa, et al.
Annals of Surgical Oncology|October 7, 2025
ASO Visual Abstract: Social Vulnerability is Associated with Significant Delays to Definitive Surgery for Stage IA-IIIA Non-small Cell Lung Cancer and Consequential Increased Rates of Pathologic UpstagingNicole M Mott, Robert A Meguid, Simran K Randhawa, et al.
The Journal of Surgical Research|March 14, 2025
The Impact of a Surgical Career on the Relationship, Family, and Personal Well-being of Surgeons' PartnersChristina M Stuart, Nicole M Mott, Alison Halpern Mungo, et al.
Journal of Surgical Oncology|May 22, 2020
Sequence of biologic therapies and surgery affects survival in non-small cell lung cancerEdison Xu, Elizabeth A David, Li Ding, et al.
The Annals of Thoracic Surgery|October 30, 2020
Adjuvant Chemotherapy Improves Survival in pN-positive Clinical Stage IIIA Non-Small Cell Lung Cancer After Neoadjuvant Therapy and ResectionScott M Atay, Maziar Amini, Li Ding, et al.
Chest|December 7, 2020
Assessing Disparities in Lung Cancer Incidence for Gender Minority Individuals Using California Cancer Registry DataLihua Liu, Jean-Christophe N Rwigema, Ziwei Song, et al.
JTO Clinical and Research Reports|September 30, 2021
Exploring the Potential Different Outcomes Associated With the Different Phenotypes Under the Shared Pathologic T3N0 DesignationTerrance Peng, Sean C Wightman, Li Ding, et al.
JTCVS Open|August 25, 2022
Lobectomy offers improved survival outcomes relative to segmentectomy for >2 but ≤4 cm non-small cell lung cancer tumorsTerrance Peng, Sean C Wightman, Li Ding, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 29, 2024
Minimally invasive versus open esophagectomy: Comparing the combined effects of smoking burden and operative approach on outcomes in esophagectomyAidan Gilbert, Rongbing Xie, Levi N Bonnell, et al.
Seminars in Thoracic and Cardiovascular Surgery|October 22, 2022
Benefit of adjuvant chemotherapy for resected pathologic N1 non-small cell lung cancer is unrecognized: A subgroup analysis of the JBR10 trialOmar Toubat, Li Ding, Keyue Ding, et al.
Pageof 14

Showing results (61-70 of 135) with videos related to

Sort By:
Pageof 14
Annals of Surgical Oncology|September 20, 2025
Social Vulnerability is Associated with Significant Delays to Definitive Surgery for Stages IA to IIIA Non-small Cell Lung Cancer and Consequential Increased Rates of Pathologic UpstagingNicole M Mott, Robert A Meguid, Simran K Randhawa, et al.
Annals of Surgical Oncology|October 7, 2025
ASO Visual Abstract: Social Vulnerability is Associated with Significant Delays to Definitive Surgery for Stage IA-IIIA Non-small Cell Lung Cancer and Consequential Increased Rates of Pathologic UpstagingNicole M Mott, Robert A Meguid, Simran K Randhawa, et al.
The Journal of Surgical Research|March 14, 2025
The Impact of a Surgical Career on the Relationship, Family, and Personal Well-being of Surgeons' PartnersChristina M Stuart, Nicole M Mott, Alison Halpern Mungo, et al.
Journal of Surgical Oncology|May 22, 2020
Sequence of biologic therapies and surgery affects survival in non-small cell lung cancerEdison Xu, Elizabeth A David, Li Ding, et al.
The Annals of Thoracic Surgery|October 30, 2020
Adjuvant Chemotherapy Improves Survival in pN-positive Clinical Stage IIIA Non-Small Cell Lung Cancer After Neoadjuvant Therapy and ResectionScott M Atay, Maziar Amini, Li Ding, et al.
Chest|December 7, 2020
Assessing Disparities in Lung Cancer Incidence for Gender Minority Individuals Using California Cancer Registry DataLihua Liu, Jean-Christophe N Rwigema, Ziwei Song, et al.
JTO Clinical and Research Reports|September 30, 2021
Exploring the Potential Different Outcomes Associated With the Different Phenotypes Under the Shared Pathologic T3N0 DesignationTerrance Peng, Sean C Wightman, Li Ding, et al.
JTCVS Open|August 25, 2022
Lobectomy offers improved survival outcomes relative to segmentectomy for >2 but ≤4 cm non-small cell lung cancer tumorsTerrance Peng, Sean C Wightman, Li Ding, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 29, 2024
Minimally invasive versus open esophagectomy: Comparing the combined effects of smoking burden and operative approach on outcomes in esophagectomyAidan Gilbert, Rongbing Xie, Levi N Bonnell, et al.
Seminars in Thoracic and Cardiovascular Surgery|October 22, 2022
Benefit of adjuvant chemotherapy for resected pathologic N1 non-small cell lung cancer is unrecognized: A subgroup analysis of the JBR10 trialOmar Toubat, Li Ding, Keyue Ding, et al.
Pageof 14